Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets-Reference-Cited by-同舟云学术

Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets

Published:2023-12 Issue:12 Volume:112 Page:3075-3087
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Shakleya Diaa^ORCID,Asmelash Bethel,Alayoubi Alaadin,Abrigo Nicolas^ORCID,Mohammad Adil^ORCID,Wang Jiang^ORCID,Zhang Jinhui,Yang Jingyue^ORCID,Marzan Tim Andres,Li David,Shaklah Maha,Alsharif Fahd M.,Desai Saaniya,Faustino Patrick J.,Ashraf Muhammad,O'Connor Thomas,Vera Matthew,Raw Andre,Sayeed Vilayat A.,Keire David^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference61 articles.

1. Cancer risk from nitrosamine-contaminated valsartan;Drug Ther Bull,2021

2. N-nitrosodimethylamine-contaminated valsartan and the risk of cancer—a longitudinal cohort study based on German health insurance data;Gomm;Dtsch Arztebl Int,2021

3. Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: danish nationwide cohort study;Pottegård;Bmj,2018

4. The contamination of valsartan and other sartans, Part 2: untargeted screening reveals contamination with amides additionally to known nitrosamine impurities;Scherf-Clavel;J Pharm Biomed Anal,2019

5. Short commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan products;Snodin;Regul Toxicol Pharmacol,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug Substances;Journal of Pharmaceutical Sciences;2024-09

2. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices;Chemical Research in Toxicology;2024-08-19

3. Analytical Procedure Development and Proposed Established Conditions: A Case Study of a Mass Spectrometry Based NDSRI Analytical Procedure;Journal of Pharmaceutical Sciences;2024-08

4. Lack of Effect of Antioxidants on Biopharmaceutics Classification System (BCS) Class III Drug Permeability;Journal of Pharmaceutical Sciences;2024-08

5. Effect of Antioxidants in Medicinal Products on Intestinal Drug Transporters;Pharmaceutics;2024-05-10